French VC Fundraising Rebounds but Remains Concentrated
French venture capital fundraising is rebounding in 2026, with €2.4 billion raised in the first half of the year—surpassing the full-year total from 2025. However, a significant portion was driven by Jeito Capital's $1.2 billion fundraise and other large biopharma commitments.
Topics: biopharma funding government investment private equity